Alpine Immune Sciences (ALPN) Misses Q4 EPS by 15c

Alpine Immune Sciences (NASDAQ: ALPN) reported Q4 EPS of ($0.41), $0.15 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.78 million versus the consensus estimate of $10.96 million.

For earnings history and earnings-related data on Alpine Immune Sciences (ALPN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c